Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi, Gilead get boosts in Japan with new Lantus & Harvoni approvals
BioPharma Dive
Tue, 07/7/15 - 10:51 am
Tags:
Sanofi, Gilead Sciences, Japan, Lantus, Harvoni, diabetes, hepatitis C
Sanofi/MannKind might be facing a major flop with Afrezza inhaled insulin
BioPharma Dive
Thu, 07/2/15 - 10:50 am
Tags:
MannKind, Sanofi, inhaled insulin, insulin, diabetes
MannKind's Afrezza: Another Look At The Early Adopters
Seeking Alpha
Sat, 06/27/15 - 11:30 am
Tags:
MannKind, Afrezza, diabetes, inhaled insulin, insulin, Sanofi
Merck cancer drugs and Sanofi, Amgen cardio meds have formularies on high alert
Fierce Pharma
Fri, 06/26/15 - 12:46 pm
Tags:
Merck, Sanofi, Amgen, formulary
Sanofi's Brandicourt faces skeptical unions, anxious shareholders
Fierce Pharma
Fri, 06/26/15 - 11:46 am
Tags:
Olivier Brandicourt, Sanofi
Report: It pays big to focus on diabetes drugs
BioPharma Dive
Thu, 06/25/15 - 11:47 am
Tags:
diabetes, Sanofi, Merck, Novo Nordisk
An interview with Sanofi's president of North American pharma
BioPharma Dive
Wed, 06/24/15 - 01:22 pm
Tags:
Sanofi, diabetes, PCSK9 inhibitors
Emerging markets still beat elsewhere for Big Pharma growth, with AstraZeneca in the lead
Fierce Pharma
Tue, 06/23/15 - 11:46 am
Tags:
emerging markets, Big Pharma, AstraZeneca, Pfizer, Sanofi
Launching MannKind's Afrezza: Sanofi's 4 Laws Of Success
Seeking Alpha
Thu, 06/18/15 - 03:58 pm
Tags:
drug launches, MannKind, Afrezza, Sanofi, diabetes, inhaled insulin
Is Amgen About to Enter a Battle Over Billions?
Investopedia
Tue, 06/16/15 - 09:10 am
Tags:
Amgen, Sanofi, Regeneron, Repatha, Praluent, PCSK9 inhibitors
Survey shows doctors ready for PCSK9s
Medical Marketing and Media
Mon, 06/15/15 - 04:24 pm
Tags:
physicians, PCSK9 inhibitors, Sanofi, Regeneron, Praluent, Amgen, Repatha
What You May Have Missed in Biotech: Cholesterol Drug Scrutiny and a Hedge Fund Alzheimer's Play
Forbes
Sat, 06/13/15 - 10:36 am
Tags:
biotech, GSK, Axovant Sciences, Alzheimer's disease, PCSK9 inhibitors, Praluent, Sanofi, Regeneron, Repatha, Amgen
Why Is Amgen Rising And Regeneron Falling?
Barron's
Fri, 06/12/15 - 10:44 am
Tags:
Amgen, Regeneron, Sanofi, Repatha, Praluent, FDA, advisory panels, PCSK9 inhibitors
India competition body cracks down on GSK, Sanofi
Fierce Vaccines
Thu, 06/11/15 - 12:06 pm
Tags:
India, GSK, Sanofi
Why Regeneron’s down on a positive FDA recommendation
CNBC
Wed, 06/10/15 - 02:36 pm
Tags:
Regeneron, Sanofi, Praluent, FDA, advisory panels, PCSK9 inhibitors
Sanofi/Regeneron's PCSK9 blockbuster-in-waiting gets prelim FDA nod
BioPharma Dive
Tue, 06/9/15 - 06:33 pm
Tags:
Sanofi, Regeneron, PCSK9 inhibitors, FDA, advisory panels, Praluent
PCSK9 adcomm preview: what's at stake
Medical Marketing and Media
Tue, 06/9/15 - 09:32 am
Tags:
PCSK9 inhibitors, FDA, advisory panels, Sanofi, Regeneron, Amgen, Repatha, Praluent
Sanofi's diabetes hopeful Lyxumia gets a raft of good safety grades
Fierce Pharma Marketing
Mon, 06/8/15 - 10:03 pm
Tags:
Sanofi, diabetes, Lyxumia
Lilly says peglispro is superior to Sanofi's Lantus
Medical Marketing and Media
Mon, 06/8/15 - 10:02 pm
Tags:
Eli Lilly, Peglispro, basal insulin, Sanofi, Lantus, diabetes, insulin
Novo Nordisk type 2 diabetes combo drug tops Sanofi's Lantus -study
Yahoo/Reuters
Sun, 06/7/15 - 10:03 am
Tags:
Novo Nordisk, type 2 diabetes, Sanofi, IDegLira, Lantus

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.